14th-17th MAY
The Stevenage Bioscience Catalyst, UK
Empowered Antibodies 2013 – 14th May 2013 - www.regonline.co.uk/ADC2013
Therapeutic Protein Production – 15th May 2013 - www.regonline.co.uk/protein2013
Biosimilars To Biobetters – 16th May 2013 - www.regonline.co.uk/biosimilar2013
Vaccine Delivery – 17th May 2013 - www.regonline.co.uk/vaccines2013
Speakers include
- Professor Roy Jefferis, PhD; CChem, FRSC; MRCP; FRCPath; DSc
- Mr Andrew Clutterbuck, Merck Millipore
- Professor Emeritus: Molecular Immunology School of Immunity & Infection University of Birmingham B15 2TT UK
- Professor Phil Blower, Kings College London, UK
- Mr Craig Malcolm, Promega UK, UK
- Sahendra Deonarain, Imperial College, London
- Dave Simpson PhD, Director, Virodigm Ltd
- Dr. Sandra Diebold, Guy’s Hospital London,
- Dr Wing Man Lau, School of Pharmacy, University of Reading, UK
- Surinder K Sharma, Head: ADEPT & Translational Therapeutics, UCL Cancer Institute
- Laura Bailey, Eden Biodesign
- Graziella El Khoury, University of Cambridge, UK
- Dr Simon Draper, The Jenner Institute, University of Oxford
- Professor Michael McDermott, Leeds Institute of Molecular Medicine, UK
- Dr Steven Patterson, Imperial College at Chelsea and Westminster Hospital, UK
- Professor Richard J Ross, University of Sheffield
- Professor Bazbek Davletov, Chair of Biomedical Sciences, University of Sheffield, UK
- Adam Bentley, Eden Biodesign
- Dr Lan Chen, Department of Chemical Engineering and Biotechnology University of Cambridge
- Jenny Thirlway, Glythera
- Professor Polly Roy, London School of Hygiene & Tropical Medicine, UK
- Dr Amin Hajitou, Imperial College Faculty of Medicine Division of Brain Sciences, Hammersmith Hospital, United Kingdom
- Dr Robert E. Zoubek, Formycon AG, Germany
If you would like to attend one or all of these events please contact Leon Pein
Email: leon.pein@euroscicon.com
Phone: (+44) 07507 799380
Leon can offer a bulk booking for all three events or for group registrations
The venue for this event will be The Stevenage Bioscience Catalyst, within the GSK complex, Stevenage, UK
The Stevenage Bioscience Catalyst campus is a unique bioscience community created to provide small biotech and life sciences companies and start-ups with access to the expertise, networks and scientific facilities traditionally associated with multinational pharmaceutical companies
Tags: AAV vectors, Affinity chromatography, Analysis, antibody, Antibody Discovery, Antibody Engineering, antibody purification, automation, biobetters, Biologicals, Biologics, biopharmaceutical, biopharmaceutical manufacturing processes, bioreactor, Biosimilar, Biosimilarity, Biosimilars, botulinum, Business Development Genomics, cell line, Cell line development, Cell line engineering, cell line selection, Characterisation, CHO, CHO cell lines, CMC, Comparability, CTD, Discovery Chemistry, domain, downstream processing, Downtream processing, drug delivery, Drug-delivery; Gene-Delivery, E.coli, endogenous genome, EU, Formulation Development, Fusion, Gene correction/modification, gene targeting, genetic algorithms, glycosylation, Growth Hormone, HIV, homologous recombination, hormones, Immunoassay, Long Acting Biological, mAbs., Malaria; Vaccine; Antibody; Immunology, mammalian expression systems, microbial, Molecular Biology and Chemistry, Molecular Discovery Research, Molecular Medicine, monoclonal antibodies, monoclonal antibody, multi-product facility design, Nanoscale, new technologies, next generation biologics, NTA, nuclear medicine, PET, Process Development, process economics, Product registration, protein, Protein Aggregation, Protein Engineering, protein linking, protein therapeutics, radionuclide therapy, radionuclides, Regulatory, Regulatory Affairs, screening., Similarity, SPECT, stapling, T cells, technologies, therapeutic, Therapeutic antibodies, therapeutic protein production, Translational Research, Vaccine, Vaccine delivery; Immunotherapy; Nanoparticles
Follow Us!